Latest Biosimilar Stories
North America is the largest contributor to the global market while Asia is expected to grow at the highest rate.
Introduces Chairman Gewanter, shows support for BQ proposal GENEVA, Oct.
A Substantial Need Remains for Emerging SLE Biologics That Can Prevent Acute Flares and That Treat Severe Manifestations, According to Findings from Decision Resources Group BURLINGTON, Mass.,
CRANBURY, N.J., Oct.
Physicians Indicate that Switching of Currently Treated Patients to Biosimilar Infliximab Is Likely to be Limited, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
- BIO Investor Forum to be held October 7-8 in San Francisco - SAN DIEGO, Oct. 1, 2014 /PRNewswire/ -- Pfenex Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).